Active

GEMAPHER

Switched

BE0865737668

Rechtspersoon Private limited company

Gebroeders Legrainlaan 85, 1150 Sint-Pieters-Woluwe

Active for

22 year, 2 months

Financials

Financial year 2025

Gross margin

€ 211,344

Profit

Healthy

€ 27,468

▼ 63% vs 2024

Debts

Low

€ 574,806

▼ 7% vs 2024

GEMAPHER from Sint-Pieters-Woluwe, company number BE0865737668, closed financial year 2025 with a result of € 27,468 after tax. For that financial year GEMAPHER recorded a gross margin of € 211,344 and equity of € 2.6 million. Compared with financial year 2024, the result moved from € 75,052 to € 27,468. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 17, 2026.

What happened at GEMAPHER?

What happened at GEMAPHER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 27,468 (▼ 63% vs 2024). filed late Source: NBB ↗
  • CAREVIEW became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 144,422 profit in 2021 to € 27,468 profit in 2025.

Paid € 178,350 in corporate taxes since 2021.

Best year ever: 2021, with € 144,422 profit.

A new publication or filing at GEMAPHER? We notify you, reason included.

Follow GEMAPHER

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind GEMAPHER is CAREVIEW. CAREVIEW is also behind GEMAMEDIC.

See the full network in the app

Directors

According to the 2025 annual accounts

CAREVIEW

Director · represented by LAURENT VANBEL, MIKE SALAVRACOS

Also active at: GEMAMEDIC

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Gebroeders Legrainlaan 85

1150 Sint-Pieters-Woluwe

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

Details

Company number
0865.737.668
VAT number
BE 0865.737.668
Registered office
Gebroeders Legrainlaan 85, 1150 Sint-Pieters-Woluwe
Names & denominations
GEMAPHER
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
11 June 2004
Peppol
Not registered

Frequently asked questions

What is the enterprise number of GEMAPHER?
The enterprise number of GEMAPHER is BE0865737668.
What is the address of GEMAPHER?
The registered office of GEMAPHER is located at Gebroeders Legrainlaan 85, 1150 Sint-Pieters-Woluwe.
When was GEMAPHER founded?
GEMAPHER was founded on 11 June 2004.
Does GEMAPHER have a website?
No website is currently known for GEMAPHER.
How much profit did GEMAPHER make in 2025?
GEMAPHER posted a profit after taxes of € 27,468 in financial year 2025.
What is the revenue of GEMAPHER?
As a small company, GEMAPHER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 211,344.
Where can I find the annual accounts of GEMAPHER?
GEMAPHER files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of GEMAPHER?
According to the 2025 annual accounts, the directors of GEMAPHER are: CAREVIEW.
Who owns GEMAPHER?
Behind GEMAPHER is CAREVIEW. CAREVIEW is also behind GEMAMEDIC.